2018
DOI: 10.1155/2018/6535816
|View full text |Cite
|
Sign up to set email alerts
|

Development of a Robust UPLC Method for Simultaneous Determination of a Novel Combination of Sofosbuvir and Daclatasvir in Human Plasma: Clinical Application to Therapeutic Drug Monitoring

Abstract: A rapid and selective UPLC-DAD method was developed and validated for simultaneous analysis of the novel two-drug combination Darvoni® for the treatment of HCV: Sofosbuvir (SF)/Daclatasvir (DC) in human plasma using Ledipasvir as internal standard (IS) where the extraction process was conducted using automated SPE. Although the analysis of the combination after concomitant oral intake of two tablets of SF and DC individually was reported in literature, yet simultaneous analysis of this new combination in human… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(2 citation statements)
references
References 25 publications
(18 reference statements)
0
1
0
Order By: Relevance
“…The coupling of UPLC with other devices different Techniques is convenient and economical as Compared to HPLC . Example: UPLC-DAD-MS/MS was used in the metabolic Of the medicinal grass Eleusine indica 32 .…”
Section: E Combination Studymentioning
confidence: 99%
“…The coupling of UPLC with other devices different Techniques is convenient and economical as Compared to HPLC . Example: UPLC-DAD-MS/MS was used in the metabolic Of the medicinal grass Eleusine indica 32 .…”
Section: E Combination Studymentioning
confidence: 99%
“…UPLC method determination of sofosbuvir and daclatasvir in human plasma for therapeutic drug monitoring 48 .…”
Section: Examples: A)mentioning
confidence: 99%